IMKURAQ is a veterinary & aquatic animal diseases care company mainly dealing with poultry & shrimp viral and bacterial diseases. The company develops feed and water additives for veterinary including poultry and aquaculture industries. This company utilizes technology developed by IgY Immunologix. IMKURAQ capabilities are to increase the speed and efficiency of progressing products. IMKURAQ provides a range of state-of- the-art products to support the rapidly growing commercial poultry and shrimp feed supplements interests in this field. The company capabilities are to increase the speed and efficiency of progressing products to control WSSV vibriosis in pond. Nanotechnology and CQD technology have driven highly potent product portfolio. IMKURAQ utilizes a truly integrated approach to develop products by utilizing expertise of its sister company Zealous Therapeutics and in collaboration with IgY Immunologix. Zealous Therapeutics is a Singapore entity with mandate to develop Pharmaceuticals new drug candidate for cancer, autoimmune disorders and infectious diseases. IgY Immunologix is an antibody technology company which has specialization for developing therapeutic and diagnostic antibodies for veterinary diseases.